SOW
PRTK

State of Wyoming’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

State of Wyoming’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,561
Closed -$56K – 2087
2021
Q4 		$56K Buy
+12,561
New +$59.6K 0.03% 1040

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

State of Wyoming's PRTK Position: Q1 2022 in Review

State of Wyoming sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q1 2022, closing a stake of 12,561 shares — an estimated $56K sold.

State of Wyoming first reported a position in PRTK in Q4 2021 and held it in 1 quarter. The position peaked at $56K in Q4 2021. 100 funds tracked by Wall St. Rank hold PRTK as of Q1 2022.

  • State of Wyoming reported no remaining Paratek Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • State of Wyoming sold 12,561 Paratek Pharmaceuticals, Inc. shares in Q1 2022, an estimated $56K.
  • State of Wyoming first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2021 and held it in 1 quarter.
  • State of Wyoming's Paratek Pharmaceuticals, Inc. position peaked at $56K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2022.

Based on State of Wyoming's 13F filing for Q1 2022, filed 13 May 2022.